These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20686374)

  • 1. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.
    Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY
    Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
    Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage 1C grade 3 endometrial cancer: the KK Hospital gynaecological oncology group experience.
    Siow TR; Yeo MC; Khoo-Tan HS; Yap SP; Soong YL; Chua EJ; Soh LT; Lim YK; Chia YN; Yam KL
    Int J Gynecol Cancer; 2010 Dec; 20(9):1557-62. PubMed ID: 21119369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
    Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
    Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.
    Townamchai K; Lee L; Viswanathan AN
    Gynecol Oncol; 2012 Nov; 127(2):351-5. PubMed ID: 22850411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
    Horowitz NS; Peters WA; Smith MR; Drescher CW; Atwood M; Mate TP
    Obstet Gynecol; 2002 Feb; 99(2):235-40. PubMed ID: 11814503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.
    Rydzewski NR; Strohl AE; Donnelly ED; Kanis MJ; Lurain JR; Nieves-Neira W; Strauss JB
    Cancer; 2016 Dec; 122(23):3724-3731. PubMed ID: 27509082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High dose rate vaginal brachytherapy in endometrial cancer after surgery].
    Moreau-Claeys MV; Brunaud C; Hoffstetter S; Buchheit I; Peiffert D
    Cancer Radiother; 2011 Jun; 15(3):169-75. PubMed ID: 21237693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
    Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence and survival in surgically treated endometrioid endometrial cancer.
    Sanjuán A; Cobo T; Escaramís G; Rovirosa A; Ordi J; García S; Hernández S; Caparrós X; Torné A; Martínez Román S; Lejárcegui JA; Pahisa J
    Clin Transl Oncol; 2008 Aug; 10(8):505-11. PubMed ID: 18667382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
    Rasool N; Fader AN; Seamon L; Neubauer NL; Shahin FA; Alexander HA; Moore K; Moxley K; Secord AA; Kunos C; Rose PG; O'Malley DM
    Gynecol Oncol; 2010 Jan; 116(1):10-4. PubMed ID: 19875158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
    Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
    Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.